Modulation of the nitric oxide metabolism overcomes the unresponsiveness of the diabetic human myocardium to protection against ischemic injury

Journal of Surgical Research

Volumn 171, Issue 2, 2011, Pages 452-456

  Barua, Anupama ^a   Standen, Nicholas B ^a   Galiñanes, Manuel ^a,b  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

^b HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

cardioprotection; diabetes; ischemic injury; nitric oxide; nitric oxide synthase

Indexed keywords

CREATINE KINASE; N(G) NITROARGININE METHYL ESTER; NEURONAL NITRIC OXIDE SYNTHASE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; PROPIDIUM IODIDE;

APOPTOSIS; ARTICLE; CELL DEATH; CONTROLLED STUDY; DIABETIC PATIENT; ELECTIVE SURGERY; ENZYME METABOLISM; ENZYME RELEASE; HEART MUSCLE; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HEART SURGERY; HUMAN; HUMAN TISSUE; ISCHEMIC PRECONDITIONING; NICK END LABELING; PRIORITY JOURNAL; REOXYGENATION; TISSUE INJURY; TISSUE SLICE;

APOPTOSIS; ATRIAL APPENDAGE; CARDIOTONIC AGENTS; DIABETES MELLITUS, TYPE 2; ENZYME INHIBITORS; HUMANS; ISCHEMIC PRECONDITIONING, MYOCARDIAL; MITOCHONDRIA; MYOCARDIAL ISCHEMIA; MYOCARDIUM; NECROSIS; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE DONORS; NITRIC OXIDE SYNTHASE; ORGAN CULTURE TECHNIQUES; RANDOM ALLOCATION; S-NITROSO-N-ACETYLPENICILLAMINE;

EID: 81155138801     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2010.07.040     Document Type: Article

References (28)

1. E.J. Feskens, and D. Kromhout Glucose tolerance and the risk of cardiovascular disease: The Zutphen Study J Clin Epidemiol 45 1992 1327
2. A.M. Calafiore, M. Di Mauro, and G. Di Giammarco Effect of diabetes on early and late survival after isolated first coronary bypass surgery in multivessel disease J Thorac Cardiovasc Surg 125 2003 144
3. B.M. Matata, and M. Galiñanes Cardiopulmonary bypass exacerbates oxidative stress but does not increase proinflammatory cytokine release in patients with diabetes compared with patients without diabetes: Regulatory effects of exogenous nitric oxide J Thorac Cardiovasc Surg 120 2000 1
4. S. Ghosh, N.B. Standen, and M. Galiñanes Failure to precondition pathological human myocardium J Am Coll Cardiol 37 2001 711
5. A. Hassouna, M. Loubani, and B.M. Matata Mitochondrial dysfunction as the cause of the failure to precondition the diabetic human myocardium Cardiovasc Res 69 2006 450
6. M. Loubani, and M. Galiñanes Pharmacological and ischemic preconditioning of the human myocardium: MitoK(ATP) channels are upstream and p38MAPK is downstream of PKC BMC Physiol 2 2002 10
7. ATP channels as effectors of human myocardial preconditioning Cardiovasc Res 45 2000 934
8. G.J. Gross, and J.N. Peart KATP channels and myocardial preconditioning: An update Am J Physiol Heart Circ Physiol 285 2003 H921
9. K.D. Garlid Opening mitochondrial K(ATP) in the heart-what happens, and what does not happen Basic Res Cardiol 95 2000 275
10. Barua A, Standen NB, Galiñanes M. Dual role of nNOS in ischemic injury and preconditioning. BMC Physiol (in press).
11. J.G. Zhang, S. Ghosh, and C.D. Ockleford Characterization of an in vitro model for the study of the short and prolonged effects of myocardial ischaemia and reperfusion in man Clin Sci (Lond) 99 2000 443
12. J.G. Zhang, and M. Galiñanes Role of the L-arginine/nitric oxide pathway in ischaemic/reoxygenation injury of the human myocardium Clin Sci (Lond) 99 2000 497
13. R.L. Handy, and P.K. Moore A comparison of the effects of L-NAME, 7-NI and L-NIL on carrageenan-induced hindpaw oedema and NOS activity Br J Pharmacol 123 1998 1119
14. M. Galiñanes, and A.G. Fowler Role of clinical pathologies in myocardial injury following ischaemia and reperfusion Cardiovasc Res 61 2004 512
15. J.R. Kersten, W.G. Toller, and E.R. Gross Diabetes abolishes ischemic preconditioning: Role of glucose, insulin, and osmolality Am J Physiol Heart Circ Physiol 278 2000 H1218
16. P. Pacher, I.G. Obrosova, and J.G. Mabley Role of nitrosative stress and peroxynitrite in the pathogenesis of diabetic complications. Emerging new therapeutical strategies Curr Med Chem 12 2005 267
17. G.M. Buga, J.M. Griscavage, and N.E. Rogers Negative feedback regulation of endothelial cell function by nitric oxide Circ Res 73 1993 808
18. S. Selemidis, G.J. Dusting, and H. Peshavariya Nitric oxide suppresses NADPH oxidase-dependent superoxide production by S-nitrosylation in human endothelial cells Cardiovasc Res 75 2007 349
19. K.D. Kroncke, K. Fehsel, and V. Kolb-Bachofen Nitric oxide: Cytotoxicity versus cytoprotection-how, why, when, and where? Nitric Oxide 1 1997 107
20. J.P. Cooke, and P.S. Tsao Cytoprotective effects of nitric oxide Circulation 88 1993 2451
21. B. Pozo-Navas, H. Stessel, and G. Wölkart Role of myocardial nitric oxide in diabetic ischemia-reperfusion dysfunction: Studies in mice with myocyte-specific overexpression of endothelial nitric-oxide synthase J Pharmacol Exp Ther 319 2006 729
22. J. Matejkova, J. Kucharska, and D. Pancza The effect of antioxidant treatment and NOS inhibition on the incidence of ischemia-induced arrhythmias in the diabetic rat heart Physiol Res 57 Suppl. 2 2008 S55
23. S.P. Jones, W.G. Girod, and A.J. Palazzo Myocardial ischemia-reperfusion injury is exacerbated in absence of endothelial cell nitric oxide synthase Am J Physiol 276 1999 H1567
24. J.P. Gratton, P. Bernatchez, and W.C. Sessa Caveolae and caveolins in the cardiovascular system Circ Res 94 2004 1408
25. L.A. Barouch, R.W. Harrison, and M.W. Skaf Nitric oxide regulates the heart by spatial confinement of nitric oxide synthase isoforms Nature 416 2002 337
26. J.R. Lancaster Jr. A tutorial on the diffusibility and reactivity of free nitric oxide Nitric Oxide 1 1997 18
27. ATP: Atrial KATP channels require SUR1. Circ Res 2008;103:1458.
28. J. Linares-Palomino, M.A. Husainy, and V.K. Lai Selective blockade of protein kinase B protects the rat and human myocardium against ischaemic injury J Physiol 588 12 2010 2173